Home > Cashflow Statement > NGL FINECHEM

NGL FINECHEM
Cashflow Statement

NGL FINECHEM is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for NGL FINECHEM
Please provide your vote to see the results

NGL FINECHEM Last 5 Year Cashflow Statement History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Profit Before Tax₹54 Cr₹27 Cr₹67 Cr₹78 Cr₹12 Cr
Adjustment ₹12 Cr₹12 Cr₹11 Cr₹4.73 Cr₹12 Cr
Changes In working Capital ₹-33 Cr₹3.26 Cr₹-47 Cr₹-34 Cr₹-0.03 Cr
Cash Flow after changes in Working Capital ₹34 Cr₹42 Cr₹31 Cr₹48 Cr₹24 Cr
Cash Flow from Operating Activities ₹20 Cr₹35 Cr₹14 Cr₹27 Cr₹20 Cr
Cash Flow from Investing Activities ₹-27 Cr₹-27 Cr₹-14 Cr₹-25 Cr₹-20 Cr
Cash Flow from Financing Activities ₹-1.08 Cr₹-1.08 Cr₹-1.08 Cr₹-1.08 Cr₹-1.30 Cr
Net Cash Inflow / Outflow ₹-7.43 Cr₹7.18 Cr₹-1.46 Cr₹1.70 Cr₹-0.39 Cr
Opening Cash & Cash Equivalents ₹7.83 Cr₹0.64 Cr₹2.10 Cr₹0.40 Cr₹0.79 Cr
Cash & Cash Equivalent on Amalgamation / Take over / Merger -----
Cash & Cash Equivalent of Subsidiaries under liquidations -----
Translation adjustment on reserves / op cash balalces frgn subsidiaries -----
Effect of Foreign Exchange Fluctuations -----
Closing Cash & Cash Equivalent ₹0.40 Cr₹7.83 Cr₹0.64 Cr₹2.10 Cr₹0.40 Cr

Compare Cashflow Statement of peers of NGL FINECHEM

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NGL FINECHEM ₹654.0 Cr -2.3% -8.9% -52.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹420,136.0 Cr 6% 4% 9.9% Stock Analytics
DIVIS LABORATORIES ₹149,680.0 Cr 4.7% 0.3% 52.4% Stock Analytics
CIPLA ₹122,390.0 Cr 7% 3.7% 7.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹110,159.0 Cr 4.1% 6.4% 25% Stock Analytics
DR REDDYS LABORATORIES ₹97,105.6 Cr 6.3% 5% -4.7% Stock Analytics


NGL FINECHEM Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NGL FINECHEM

-2.3%

-8.9%

-52.7%

SENSEX

5.8%

6.1%

4.7%


You may also like the below Video Courses